March 6, 2023 Epicrispr Biotechnologies Announces Presentations at Upcoming Scientific and Medical Conferences
December 7, 2022 Amber Salzman, Ph.D., CEO of Epicrispr Biotechnologies, Recognized by Endpoints News as One of the Most Influential Women in Biopharma R&D
October 31, 2022 Epicrispr Biotechnologies Presents First Data Supporting Persistent and Tunable Gene Activation Using Transient Delivery
October 25, 2022 Epicrispr Biotechnologies to Participate in the 6th International Conference on Epigenetics and Bioengineering
October 13, 2022 Epicrispr Biotechnologies Presents Proprietary Gene Expression Modulation System (GEMS) Demonstrating Precise Engineering of DUX4 Gene in Facioscapulohumeral Muscular Dystrophy
October 6, 2022 Epicrispr Biotechnologies to Participate in the Solebury / BMO Fall Private Company Showcase
July 12, 2022 Epicrispr Biotechnologies, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering
